The proposed model starts with an eligible patient, not a broad systemic claim. Periodontal Medicine 2.0 does not present a completed reform. It offers a testable way to address a basic problem: research can find oral-systemic associations without turning them into coordinated patient care.
Periodontal assessment remains anchored in probing depth, clinical attachment level, bleeding on probing, suppuration, recession, furcation involvement, tooth mobility and radiographic bone levels-not broad systemic screening claims.
PM2.0 has four domains. Integrated oral-systemic screening would use selective, risk-based assessment instead of indiscriminate testing. Interprofessional care would link dental and medical services through coordinated referrals and treatment pathways. Precision periodontal medicine would tailor management to the individual. Population health and policy integration would take the model beyond the clinic into prevention and health-system planning.
The ambition is broad. The status is limited. Screening is presented as appropriate only when there is a clinically meaningful condition, a validated test, a confirmatory pathway and a defined professional role. A positive result is a risk signal, not a diagnosis.
A recent peer-reviewed review describes salivary and gingival-crevicular-fluid biomarkers as promising indicators of periodontal activity while emphasizing that they are still being validated. That trajectory supports precision intervention, but not the assumption that a biomarker is already a clinically decisive test.
That distinction matters in public-health planning. A national oral-health survey can map disease and inform policy. PM2.0 asks what happens after risk is identified: who receives the referral, how care is coordinated and whether the intervention produces measurable benefit for patients and communities.
The proposed pathway begins with an eligible patient and a validated risk assessment or screening test. A positive result should lead to a documented referral. The next steps are confirmatory diagnosis and appropriate management, with feedback to dental care where relevant. The sequence does not assign dental professionals responsibility for treating systemic disease.
The framework also rests on standard periodontal diagnosis. A full examination still measures probing depth, clinical attachment level, bleeding on probing, suppuration, recession, furcation involvement and mobility. It also includes radiographic assessment of bone levels. Systemic risk assessment cannot replace a determination of the periodontal condition itself.
Those safeguards shape the research agenda. PM2.0 could be tested through clinical outcomes, patient-reported outcomes, implementation measures, economic evaluation and equity outcomes. Its authors describe the framework as unvalidated and in need of empirical testing. They do not present it as an established model of care.
Evidence calibration matters when periodontal findings are linked to major systemic outcomes. Recent clinical caution, including discussion of Cochrane-level limitations, indicates that evidence is insufficient to claim periodontal treatment prevents heart attack, stroke or cardiovascular death. Associations may support research and carefully defined referral pathways. They do not establish a cardiovascular-prevention effect by themselves.
The restraint is the framework's strongest feature. Periodontal medicine will gain practical credibility by proving which screening links, referral routes and individualized interventions improve care in real settings. PM2.0 offers a structure for that test. The value will depend on whether future evidence shows measurable benefit for patients and populations.
